UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania

Public research footprint of UPMC Hillman Cancer Center, compiled from the ClinicalTrials.gov public registry.

642

Registered studies

410

Active

193

Recruiting now

133

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Non-Cutaneous Melanoma · Recurrent Cutaneous Melanoma · Recurrent Head and Neck Squamous Cell Carcinoma · Clinical Stage III Cutaneous Melanoma AJCC v8

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UPMC Hillman Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.